Additional file 11 of Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis

免疫-微生物互作

Additional file 11: Table S10. Relationship between hub MitoDEGs and immune cells.

Figshare2024-08-13 更新50

Table_2_Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy.XLSX

糖尿病心肌病分子机制

心血管药物多组学研究

BackgroundMetabolic and energy disorders are considered central to the etiology of diabetic cardiomyopathy (DCM). Sodium-glucose cotransporter-2 inhibitors (SGLT2i) can effectively reduce the risk of

NIAID Data Ecosystem30

Data_Sheet_6_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunction.csv

糖尿病心肌病分子机制

枢纽基因分析

Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. The aim of this study

NIAID Data Ecosystem20